Damiaplant is a combination of five well-known homoeopathic remedies such as Damiana, Ginseng, Agnus castus, Nuphar luteum and Muira puama, which is effective in the treatment of weak vitality in both sexes.
Dr Willmar Schwabe India Damiaplant
₹450.00
Description
For weak vitality in male
• A combination of five well known homoeopathic remedies- Damiana- Ginseng – Agnus castus- Nuphar luteum- Muira puama
• No reported side effects.
*Do not self-medicate. Please consult your physician.
Dosage: Unless otherwise prescribed, 10-20 drops should be taken 3 – 4 times a day.
Note: For patients with serious liver or alcohol problems, in particular, please note that this product contains alcohol.
Side effects: No side effects of Damiaplant are known.
Contra-indications: Damiaplant is not indicated for children.
Interactions: No interactions between Damiaplant and other products are known.
Expiry: 5 years for the date of manufacturing.
Additional information
| size |
|---|
Manufacturer Details:
Dr. Willmar Schwabe India Pvt. Ltd. A-36, Sector-60, Uttar Pradesh, Noida – 201304.
Country of Origin: India.
Registered office Address: Dr. Willmar Schwabe India Pvt. Ltd. H-36, Green Park Extension, New Delhi, Pin: 110016.
You must be logged in to post a review.
Related products
-
₹175.00Used to treat acne, pimples, scars and to maintain a blemish free skin.
Select options This product has multiple variants. The options may be chosen on the product page -
₹175.00Used to treat severe or painful headache, feeling of nausea, vomiting, and light sensitivity.
Select options This product has multiple variants. The options may be chosen on the product page -
₹175.00Used to relieve toothaches, pain and sensitivity in teeth and gums and painful cavities.
Select options This product has multiple variants. The options may be chosen on the product page -
₹185.00Is well-known for its antipsychotic and antihypertensive action.
Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.